CAR-T cell therapy
See all stories about CAR-T cell therapy, and learn how Johnson and Johnson is innovating to cure cancer.
Hidden in large amounts of digital information—such as anonymized medical records—may be the keys to transforming the future of healthcare. Troy C. Sarich, Ph.D., Johnson & Johnson’s Chief Commercial Data Science Officer, shares how the company is carefully collecting, analyzing and harnessing this information to improve the health of people everywhere.
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
Johnson & Johnson executive Jennifer Taubert named to 2021 Fortune Most Powerful Women in Business list
It’s the sixth year in a row that the company leader has placed on the list, which honors 50 women at the top of their industries.
I have a vision for helping advance healthcare: Meet 6 leaders working on inspiring innovations in 2020
From robotics solutions for orthopedic surgery to the potential to bring new hope to patients living with multiple myeloma through CAR-T, these are just some of the cutting-edge projects that these visionaries think could potentially help propel healthcare forward around the globe.
From a $10 million pledge to UNICEF in support of health workers to promising news about a preventive HIV vaccine regimen, the company’s new 2018 Health for Humanity Report details how Johnson & Johnson is dedicated to creating a better future for everyone, everywhere.
Brad Heidrich’s diagnosis with a deadly cancer at age 13 changed the course of his life—and inspired the person he would become: a Janssen scientist dedicated to working on therapies for blood cancer. For National Cancer Survivor Month, we share his incredible story.
Hundreds of millions of people worldwide have type 2 diabetes. And Chiara Magnone has her sights set on changing what it means to live with the condition, as well as how common complications like chronic kidney disease are treated.
Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.
“Finding a cure is personal": 3 scientists share what it’s like to work on a disease that’s touched their lives
Bringing your passion to work has taken on new meaning for these inspiring Johnson & Johnson researchers.
It’s been in the news, but what does CAR-T really mean for patients? Immuno-oncology expert Iqbal Grewal, Ph.D., explains why the treatment has the potential to be a game changer for people with all types of cancer down the road.